The immune checkpoint inhibitors market is primarily driven by the increasing prevalence of cancer, rising investment in ...

As the interplay between export controls, trade sanctions, and anticorruption enforcement continues to intensify, ...

Qdenga®, which is undergoing further global registrations, is expected to face competition in the PAHO region from Instituto ...

Masimo said on Wednesday that Joe Kiani has decided to resign as CEO, days after shareholders voted to remove him from the company's board.

We assessed the long-term effects and cost-effectiveness of statin therapy for older people in the contemporary UK population ...

Iterum Therapeutics faces a mixed reception for its therapy for uncomplicated urinary tract infections (UTIs) as experts ...

SiS – the leading Women’s Health platform facilitating impact in women’s health innovation – has announced its inaugural ...

UMC Utrecht (LJB and NIM) received grants from AbbVie, AstraZeneca, The Bill & Melinda Gates Foundation, the Dutch Lung Foundation, The Gates Medical Research Institute, GlaxoSmithKline (GSK), Janssen ...

MWINYI, The First Lady of the Zanzibar Senator, Dr. Rasha Kelej, CEO of Merck Foundation and Chairperson of Merck Foundation Africa Asia Luminary shared, "We are excited to announce the 11th Edition ...

The European stock markets closed lower in Friday trading as the FTSE in London was down 1.19%, Germany's DAX slipped 1.49%, France's CAC lost 1.51%, the Stoxx Europe 600 fell 1.42% and the Swiss ...

The major European markets are down in negative territory on Friday with investors assessing the likely impact of the monetary policy ...

Merck & Co. said a European Medicines Agency panel recommended expanded approval of the drugmaker's blockbuster cancer treatment Keytruda in two types of gynecologic cancers.